References
- Ritchie H, Roser M. Drug use. Our World in Data; 2019. Available from: https://ourworldindata.org/drug-use.
- Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008;455(7215):894–902.
- Mendlewicz J, Kriwin P, Oswald P, Souery D, Alboni S, Brunello NJ. Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. Int Clin Psychopharmacol. 2006;21(4):227–31.
- Vieta E, Colom F. Therapeutic options in treatment-resistant depression. Ann Med. 2011;43(7):512–30.
- Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28–40.
- Kulkarni SK, Dhir A. σ-1 receptors in major depression and anxiety. Expert Rev Neurother. 2009;9(7):1021–34.
- Cryan JF, Leonard BE. Depression: from psychopathology to pharmacotherapy. Karger Medical and Scientific Publishers; 2010.
- Dobrzański Z, Bykowski P, Iwaniuk Z, Usydus Z, Górecka H, Trziszka T. Evaluation of the chemical composition of fish oil: a by-product from fish processing plants. Bull Sea Fish Inst. 2002;1(155):39–46.
- Egerton S, Mannion D, Culloty S, Whooley J, Stanton C, Ross RP. The proximate composition of three marine pelagic fish; blue whiting (Micromesistius poutassou), boarfish (Capros aper) and Atlantic herring (Clupea harengus). Ir J Agric Food Res. 2020. In press
- Ahn SH, Lim SJ, Ryu YM, Park H-R, Suh HJ, Han SH. Absorption rate of krill oil and fish oil in blood and brain of rats. Lipids Health Dis. 2018;17(1):162.
- Kitson AP, Metherel AH, Chen CT, Domenichiello AF, Trépanier M-O, Berger A, Bazinet RP. Effect of dietary docosahexaenoic acid (DHA) in phospholipids or triglycerides on brain DHA uptake and accretion. J Nutr Biochem. 2016;33:91–102. doi:https://doi.org/10.1016/j.jnutbio.2016.02.009.
- Schuchardt JP, Schneider I, Meyer H, Neubronner J, von Schacky C, Hahn A. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations - a comparative bioavailability study of fish oil vs. krill oil. Lipids Health Dis. 2011;10(1):145. doi:https://doi.org/10.1186/1476-511X-10-145.
- Luchtman DW, Song C. Cognitive enhancement by omega-3 fatty acids from child-hood to old age: findings from animal and clinical studies. Neuropharmacology. 2013;64:550–65.
- Sontrop J, Campbell MK. Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Prev Med. 2006;42(1):4–13. doi:https://doi.org/10.1016/j.ypmed.2005.11.005. PubMed PMID: 16337677.
- Mello AH, Gassenferth A, Souza LR, Fortunato JJ. Rezin GT. omega-3 and major depression: a review. Acta Neuropsychiatr. 2014;26(3):178–85. doi:https://doi.org/10.1017/neu.2013.52. PubMed PMID: 25142194.
- Song C, Manku MS, Horrobin DF. Long-chain polyunsaturated fatty acids modulate interleukin-1 β–induced changes in behavior, monoaminergic neurotransmitters, and brain inflammation in rats. J Nutr. 2008;138(5):954–63.
- Vines A, Delattre AM, Lima MM, Rodrigues LS, Suchecki D, Machado RB, et al. The role of 5-HT(1)A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism. Neuropharmacology. 2012;62(1):184–91. doi:https://doi.org/10.1016/j.neuropharm.2011.06.017. PubMed PMID: 21740919.
- Gilbert K, Bernier J, Godbout R, Rousseau G. Resolvin D1, a metabolite of omega-3 polyunsaturated fatty acid, decreases post-myocardial infarct depression. Mar Drugs. 2014;12(11):5396–407. doi:https://doi.org/10.3390/md12115396. PubMed PMID: 25402828; PMCID: 4245537.
- Dinan T, Siggins L, Scully P, O’Brien S, Ross P, Stanton CJ. Investigating the inflammatory phenotype of major depression: focus on cytokines and polyunsaturated fatty acids. J Psychiatr Res. 2009;43(4):471–6.
- Pusceddu M, Nolan Y, Green H, Kelly P, Cryan J, Dinan T. Docosahexaenoic acid as a novel strategy for stress-related disorders: reversal of corticosterone-induced changes in cortical neurons. Eur Neuropsychopharmacol. 2015;25:S130.
- Robertson RC, Seira Oriach C, Murphy K, Moloney GM, Cryan JF, Dinan TG, et al. Omega-3 polyunsaturated fatty acids critically regulate behaviour and gut microbiota development in adolescence and adulthood. Brain Behav Immun. 2017;59:21–37. doi:https://doi.org/10.1016/j.bbi.2016.07.145. PubMed PMID: 27423492.
- Dinan TG, Cryan JF. Brain–gut–microbiota axis — mood, metabolism and behaviour. Nat Rev Gastroenterol Hepatol. 2017;14(2):69–70. doi:https://doi.org/10.1038/nrgastro.2016.200. PubMed PMID: 28053341.
- Mayer EA, Ryu HJ. The gut-brain axis and microbiome in psychiatric disorders. In: Noordsy DL, editor. Lifestyle psychiatry. Washington, DC: American Psychiatric Association Publishing; 2019. p. 239–260.
- Zhou L, Foster JA. Psychobiotics and the gut-brain axis: in the pursuit of happiness. Neuropsychiatr Dis Treat. 2015;11:715–23. doi:https://doi.org/10.2147/NDT.S61997. PubMed PMID: 25834446; PMCID: 4370913.
- Kelly JR, Minuto C, Cryan JF, Clarke G, Dinan TG. Cross talk: the microbiota and neurodevelopmental disorders. Front Neurosci. 2017;11:490. doi:https://doi.org/10.3389/fnins.2017.00490. PubMed PMID: 28966571; PMCID: 5605633.
- Sherwin E, Dinan TG, Cryan JF. Recent developments in understanding the role of the gut microbiota in brain health and disease. Ann N Y Acad Sci. 2018;1420(1):5–25. doi:https://doi.org/10.1111/nyas.13416. PubMed PMID: 28768369.
- Leclercq S, Stärkel P, Delzenne NM, de Timary PJA. The gut microbiota: a new target in the management of alcohol dependence? Alcohol. 2019;74:105–11.
- Watson H, Mitra S, Croden FC, Taylor M, Wood HM, Perry SL, et al. A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota. Gut. 2018;67(11):1974–83.
- Cryan JF, O’Riordan KJ, Cowan CS, Sandhu KV, Bastiaanssen TF, Boehme M, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;99(4):1877–2013.
- Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050–5.
- Costantini L, Molinari R, Farinon B, Merendino N. Impact of omega-3 fatty acids on the gut microbiota. Int J Mol Sci. 2017;18:12. doi:https://doi.org/10.3390/ijms18122645. PubMed PMID: 29215589; PMCID: 5751248.
- Anderson RC, Cookson AL, McNabb WC, Park Z, McCann MJ, Kelly WJ, Roy NC. Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol. 2010;10(1):316.
- Wang X, Pan L, Lu J, Li N, Li J. N-3 PUFAs attenuate ischemia/reperfusion induced intestinal barrier injury by activating I-FABP-PPARγ pathway. Clin Nutr. 2012;31(6):951–7.
- Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010;142(5):687–98. doi:https://doi.org/10.1016/j.cell.2010.07.041. PubMed PMID: 20813258; PMCID: 2956412.
- Koopman M, El Aidy S. Depressed gut? The microbiota-diet-inflammation trialogue in depression. Curr Opin Psychiatry. 2017;30(5):369–77. doi:https://doi.org/10.1097/yco.0000000000000350. PubMed PMID: 00001504-201709000-00009.
- Sakata T. Pitfalls in short-chain fatty acid research: a methodological review. ASJ. 2019;90(1):3–13.
- Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. JNRI. 2016;16(6):341–52.
- Syed SA, Nemeroff CB. Early life stress, mood, and anxiety disorders. JCS. 2017;1:2470547017694461.
- O’Mahony SM, Hyland NP, Dinan TG, Cryan JF. Maternal separation as a model of brain-gut axis dysfunction. Psychopharmacology. 2011;214(1):71–88. doi:https://doi.org/10.1007/s00213-010-2010-9. PubMed PMID: 20886335.
- O’Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho AM, Quigley EM, et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry. 2009;65(3):263–7. doi:https://doi.org/10.1016/j.biopsych.2008.06.026. PubMed PMID: 18723164.
- Bailey MT, Coe CL. Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys. Dev Psychobiol. 1999;35(2):146–55. Epub 1999/08/26. PubMed PMID: 10461128.
- Cowan CSM, Stylianakis AA, Richardson R. Early-life stress, microbiota, and brain development: probiotics reverse the effects of maternal separation on neural circuits underpinning fear expression and extinction in infant rats. Dev Cogn Neurosci. 2019;37:100627. doi:https://doi.org/10.1016/j.dcn.2019.100627. Epub 2019/04/15. PubMed PMID: 30981894.
- Fukui H, Oshima T, Tanaka Y, Oikawa Y, Makizaki Y, Ohno H, et al. Effect of probiotic Bifidobacterium bifidum G9-1 on the relationship between gut microbiota profile and stress sensitivity in maternally separated rats. Sci Rep. 2018;8(1):12384. Epub 2018/08/19. doi:https://doi.org/10.1038/s41598-018-30943-3. PubMed PMID: 30120330; PMCID: PMC6098190.
- Neufeld KA M, O’Mahony SM, Hoban AE, Waworuntu RV, Berg BM, Dinan TG, Cryan JF. Neurobehavioural effects of Lactobacillus rhamnosus GG alone and in combination with prebiotics polydextrose and galactooligosaccharide in male rats exposed to early-life stress. Nutr Neurosci. 2019;22(6):425–34. Epub 2017/11/28. doi:https://doi.org/10.1080/1028415X.2017.1397875. PubMed PMID: 29173065.
- Laaksonen K, Nevalainen T, Haasio K, Kasanen I, Nieminen P, Voipio HM. Food and water intake, growth, and adiposity of Sprague-Dawley rats with diet board for 24 months. Lab Anim. 2013;47(4):245–56.
- Arndt DL, Peterson CJ, Cain ME. Differential rearing alters forced swim test behavior, fluoxetine efficacy, and post-test weight gain in male rats. PloS one. 2015;10(7):e0131709.
- Pusceddu MM, El Aidy S, Crispie F, O’Sullivan O, Cotter P, Stanton C, et al. N-3 polyunsaturated fatty acids (PUFAs) reverse the impact of early-life stress on the gut microbiota. PloS one. 2015;10(10):e0139721.
- Cryan JF, Kelly PH, Chaperon F, Gentsch C, Mombereau C, Lingenhoehl K, et al. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N, N′-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4, 6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J Pharmacol Exp Therap. 2004;310(3):952–63.
- Seibenhener ML, Wooten MC. Use of the open field maze to measure locomotor and anxiety-like behavior in mice. JoVE. 2015;96:e52434.
- O’Mahony S, Felice V, Nally K, Savignac H, Claesson M, Scully P, et al. Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats. Neuroscience. 2014;277:885–901.
- Porsolt RD, Bertin A, Jalfre MJ. “Behavioural despair” in rats and mice: strain differences and the effects of imipramine. European J Pharmacol. 1978;51(3):291–4.
- Slattery DA, Cryan JF. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc. 2012;7(6):1009–1014.
- Pusceddu MM, Kelly P, Ariffin N, Cryan JF, Clarke G, Dinan TG. n-3 PUFAs have beneficial effects on anxiety and cognition in female rats: effects of early life stress. Psychoneuroendocrinology. 2015;58:79–90. doi:https://doi.org/10.1016/j.psyneuen.2015.04.015. PubMed PMID: 25965872.
- Clarke, G, Grenham, S, Scully, P, Fitzgerald, P, Moloney, RD, Shanahan, et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psy. 2013;18(6):666–73.
- Folch J, LeBaron FN. Metabolism of the nervous system. Richter D, editor. London: Pergamon Press Ltd; 1957.
- Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335–336.
- Edgar R. Usearch. Berkeley (CA): Lawrence Berkeley National Lab.(LBNL); 2010.
- Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2012;41(D1):D590–D6.
- Zakrzewski M, Proietti C, Ellis JJ, Hasan S, Brion M-J, Berger B, Krause LJ. Calypso: a user-friendly web-server for mining and visualizing microbiome–environment interactions. Bioinformatics. 2017;33(5):782–3.
- Tengeler AC, Kozicz T, Kiliaan AJ. Relationship between diet, the gut microbiota, and brain function. Nutr Rev. 2018;76(8):603–17.
- Fava F, Rizzetto L, Tuohy K. Gut microbiota and health: connecting actors across the metabolic system. Proc Nutr Soc. 2019;78(2):177–88.
- Mathieu G, Oualian C, Denis I, Lavialle M, Gisquet-Verrier P, Vancassel S. Dietary n-3 polyunsaturated fatty acid deprivation together with early maternal separation increases anxiety and vulnerability to stress in adult rats. Prostaglandins Leukot Essent Fatty Acids. 2011;85(3-4):129–36. doi:https://doi.org/10.1016/j.plefa.2011.07.001. PubMed PMID: 21784625.
- Zhang L, Hernández VS, Liu B, Medina MP, Nava-Kopp AT, Irles C, Morales M. Hypothalamic vasopressin system regulation by maternal separation: its impact on anxiety in rats. Neuroscience. 2012;215:135–48. doi:https://doi.org/10.1016/j.neuroscience.2012.03.046.
- Réus GZ, Stringari RB, Ribeiro KF, Cipriano AL, Panizzutti BS, Stertz L, et al. Maternal deprivation induces depressive-like behaviour and alters neurotrophin levels in the rat brain. Neurochem Res. 2011;36(3):460–6.
- Leussis MP, Freund N, Brenhouse HC, Thompson BS, Andersen SL. Depressive-like behavior in adolescents after maternal separation: sex differences, Controllability, and GABA. Dev Neurosci. 2012;34(2-3):210–7. doi:https://doi.org/10.1159/000339162.
- Sousa VC, Vital J, Costenla AR, Batalha VL, Sebastião AM, Ribeiro JA, Lopes LV. Maternal separation impairs long term-potentiation in CA1-CA3 synapses and hippocampal-dependent memory in old rats. Neurobiol Aging. 2014;35(7):1680–5.
- Wang L, Jiao J, Dulawa SC. Infant maternal separation impairs adult cognitive performance in BALB/cJ mice. Psychopharmacology. 2011;216(2):207–18.
- Harrison EL, Baune BT. Modulation of early stress-induced neurobiological changes: a review of behavioural and pharmacological interventions in animal models. Transl Psychiatry. 2014;4:e390. doi:https://doi.org/10.1038/tp.2014.31. PubMed PMID: 24825729; PMCID: 4035722.
- Sidhu KS. Health benefits and potential risks related to consumption of fish or fish oil. Regul Toxicol Pharmacol. 2003;38(3):336–44. doi:https://doi.org/10.1016/j.yrtph.2003.07.002.
- Milaneschi Y, Hoogendijk W, Lips P, Heijboer AC, Schoevers R, van Hemert AM, et al. The association between low vitamin D and depressive disorders. Mol Psychiatry. 2014;19(4):444–51. doi:https://doi.org/10.1038/mp.2013.36.
- Kabir ZD, Martínez-Rivera A, Rajadhyaksha AM. From gene to behavior: L-type calcium channel mechanisms underlying neuropsychiatric symptoms. Neurotherapeutics. 2017;14(3):588–613.
- Jamilian M, Shojaei A, Samimi M, Afshar Ebrahimi F, Aghadavod E, Karamali M, et al. The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome. J Affect Disord. 2018;229:41–7. doi:https://doi.org/10.1016/j.jad.2017.12.049.
- Hu P, van Dam A-M, Wang Y, Lucassen PJ, Zhou J-N. Retinoic acid and depressive disorders: evidence and possible neurobiological mechanisms. Neurosci Biobehav Rev. 2020. doi:https://doi.org/10.1016/j.neubiorev.2020.02.013.
- Serefko A, Szopa A, Poleszak EJ. Magnesium and depression. Magnesium Res. 2016;29(3):112–9.
- Su K-P. Inflammation in psychopathology of depression: clinical, biological, and therapeutic implications. BioMedicine. 2012;2(2):68–74.
- Miyamoto J, Igarashi M, Watanabe K, Karaki S-i, Mukouyama H, Kishino S, et al. Gut microbiota confers host resistance to obesity by metabolizing dietary polyunsaturated fatty acids. Nat Commun. 2019;10(1):1–15.
- Thakur AK, Shakya A, Husain GM, Emerald M, Kumar V. Gut-microbiota and mental health: current and future perspectives. J Pharmacol Clin Toxicol. 2014;2(1):1016.
- Agustí A, García-Pardo MP, López-Almela I, Campillo I, Maes M, Romaní-Pérez M, Sanz Y. Interplay between the gut-brain axis, obesity and cognitive function. Front Neurosci. 2018;12:155. doi:https://doi.org/10.3389/fnins.2018.00155.
- Heim C, Newport DJ, Heit S, Graham YP, Wilcox M, Bonsall R, et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. Jama. 2000;284(5):592–7.
- Pech J, Forman J, Kessing LV, Knorr U. Poor evidence for putative abnormalities in cerebrospinal fluid neurotransmitters in patients with depression versus healthy non-psychiatric individuals: a systematic review and meta-analyses of 23 studies. J Affect Disord. 2018;240:6–16. doi:https://doi.org/10.1016/j.jad.2018.07.031. PubMed PMID: 30041075.
- Romano A, Koczwara JB, Gallelli CA, Vergara D, Di Bonaventura MV M, Gaetani S, Giudetti AM. Fats for thoughts: an update on brain fatty acid metabolism. Int J Biochem Cell Biol. 2017;84:40–5. doi:https://doi.org/10.1016/j.biocel.2016.12.015. PubMed PMID: 28065757.
- Brady LS, Gold PW, Herkenham M, Lynn AB, Whitfield HJ. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain Res. 1992;572(1):117–25. doi:https://doi.org/10.1016/0006-8993(92)90459-M.
- David DJ, Samuels BA, Rainer Q, Wang J-W, Marsteller D, Mendez I, et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron. 2009;62(4):479–93. doi:https://doi.org/10.1016/j.neuron.2009.04.017.
- Heydendael W, Jacobson L. Widespread hypothalamic–pituitary–adrenocortical axis-relevant and mood-relevant effects of chronic fluoxetine treatment on glucocorticoid receptor gene expression in mice. Eur J Neurosci. 2010;31(5):892–902. doi:https://doi.org/10.1111/j.1460-9568.2010.07131.x.
- Elhwuegi AS. Central monoamines and their role in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2004;28(3):435–51. doi:https://doi.org/10.1016/j.pnpbp.2003.11.018. PubMed PMID: 15093950.
- Logan AC. Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. Altern Med Rev. 2003;8(4):410–25.
- Bortolato M, Chen K, Shih JC. The degradation of serotonin: role of MAO. In: Müller CP, Jacobs BL, editors. Handbook of behavioral neuroscience. Elsevier; 2010. Vol 21, p. 203–18. doi:https://doi.org/10.1016/S1569-7339(10)70079-5.
- Cryan JF, Leonard BE. 5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response. Hum Psychopharmacol: Clin Exp. 2000;15(2):113–35.
- Shishkina GT, Kalinina TS, Dygalo NN. Effects of swim stress and fluoxetine on 5-HT1A receptor gene expression and monoamine metabolism in the rat brain regions. Cell Mol Neurobiol. 2012;32(5):787–94. doi:https://doi.org/10.1007/s10571-012-9828-0. PubMed PMID: 22453856.
- McNamara RK, Able JA, Liu Y, Jandacek R, Rider T, Tso P, Lipton JW. Omega-3 fatty acid deficiency does not alter the effects of chronic fluoxetine treatment on central serotonin turnover or behavior in the forced swim test in female rats. Pharmacol Biochem Behav. 2013;114-115:1–8. doi:https://doi.org/10.1016/j.pbb.2013.09.010. PubMed PMID: 24090922; PMCID: 3845450.
- Mukherjee J, Yang ZY. Monoamine oxidase A inhibition by fluoxetine: an in vitro and in vivo study. Synapse. 1999;31(4):285–9.
- Mukherjee J, Yang Z-Y. Evaluation of monoamine oxidase B inhibition by fluoxetine (Prozac): an in vitro and in vivo study. Eur J Pharmacol. 1997;337(1):111–4.
- Sandhu KV, Sherwin E, Schellekens H, Stanton C, Dinan TG, Cryan JF. Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry. Transl Res. 2017;179:223–44.
- Agans R, Gordon A, Kramer DL, Perez-Burillo S, Rufián-Henares JA, Paliy O. Dietary fatty acids sustain the growth of the human gut microbiota. Appl Environ Microbiol. 2018;84(21):e01525–18.
- Ohue-Kitano R, Yasuoka Y, Goto T, Kitamura N, Park S-B, Kishino S, et al. α-Linolenic acid–derived metabolites from gut lactic acid bacteria induce differentiation of anti-inflammatory M2 macrophages through G protein-coupled receptor 40. FASEB J. 2018;32(1):304–18.
- Dos Santos RG, de Lima Osório F, Martin-Santos R, Zuardi AW, Hallak JEC, Crippa JAS. Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment Approach for social anxiety disorder. CNS Drugs. 2019;33:1–8.
- Che Y, Zhou Z, Shu Y, Zhai C, Zhu Y, Gong S, et al. Chronic unpredictable stress impairs endogenous antioxidant defense in rat brain. Neurosci Lett. 2015;584:208–13. doi:https://doi.org/10.1016/j.neulet.2014.10.031.
- McNamara RK, Liu Y. Reduced expression of fatty acid biosynthesis genes in the prefrontal cortex of patients with major depressive disorder. J Affect Disord. 2011;129(1-3):359–63.
- Sublette ME, Milak MS, Hibbeln JR, Freed PJ, Oquendo MA, Malone KM, et al. Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression. Prostaglandins, Leukotrienes Essent Fatty Acids. 2009;80(1):57–64.
- Kelly JR, Borre Y COB, Patterson E, El Aidy S, Deane J, Kennedy PJ, et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res. 2016;82:109–18. doi:https://doi.org/10.1016/j.jpsychires.2016.07.019. PubMed PMID: 27491067.
- Tillmann S, Abildgaard A, Winther G, Wegener G. Altered fecal microbiota composition in the Flinders sensitive line rat model of depression. Psychopharmacology. 2018. doi:https://doi.org/10.1007/s00213-018-5094-2.
- Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015;48:186–94.
- Provensi G, Schmidt SD, Boehme M, Bastiaanssen TF, Rani B, Costa A, et al. Preventing adolescent stress-induced cognitive and microbiome changes by diet. Proc Natl Acad Sci U S A. 2019;116(19):9644–51.
- Robertson RC, Oriach CS, Murphy K, Moloney GM, Cryan JF, Dinan TG, et al. Deficiency of essential dietary n-3 PUFA disrupts the caecal microbiome and metabolome in mice. Br J Nutr. 2017;118(11):959–70.
- Koliada A, Syzenko G, Moseiko V, Budovska L, Puchkov K, Perederiy V, et al. Association between body mass index and Firmicutes/bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 2017;17(1):120. doi:https://doi.org/10.1186/s12866-017-1027-1.
- Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102(31):11070–5. doi:https://doi.org/10.1073/pnas.0504978102. Epub 07/20. PubMed PMID: 16033867.
- Rajilić–Stojanović M, Biagi E, Heilig HGHJ, Kajander K, Kekkonen RA, Tims S, de Vos WM. Global and deep molecular analysis of microbiota Signatures in Fecal samples from patients With irritable bowel syndrome. Gastroenterology. 2011;141(5):1792–801. doi:https://doi.org/10.1053/j.gastro.2011.07.043.
- Liu Y, Zhang L, Wang X, Wang Z, Zhang J, Jiang R, et al. Similar fecal microbiota signatures in patients with diarrhea-predominant irritable bowel syndrome and patients with depression. Clin Gastroenterol Hepatol. 2016;14(11):1602–11.
- Jeffery IB, O’Toole PW, Öhman L, Claesson MJ, Deane J, Quigley EMM, Simrén M. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut. 2012;61(7):997–1006.
- Desbonnet L, Clarke G, Shanahan F, Dinan TG, Cryan JF. Microbiota is essential for social development in the mouse. Mol Psychiatry. 2014;19(2):146.
- Lin P, Ding B, Feng C, Yin S, Zhang T, Qi X, et al. Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder. J Affect Disord. 2017;207:300–4. doi:https://doi.org/10.1016/j.jad.2016.09.051.
- Dinan TG, Cryan JF. Gut feelings on Parkinson’s and depression. Cerebrum. 2017;2017:cer-04-17 . PubMed PMID: 28698775.
- Anderson G, Seo M, Berk M, Carvalho A F, Maes M. Gut permeability and microbiota in Parkinson’s disease: role of depression, tryptophan catabolites, oxidative and nitrosative stress and melatonergic pathways. Curr Pharm Des. 2016;22(40):6142–51.
- Houlden A, Goldrick M, Brough D, Vizi ES, Lénárt N, Martinecz B, et al. Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production. Brain Behav Immun. 2016;57:10–20.
- Balfegó M, Canivell S, Hanzu FA, Sala-Vila A, Martínez-Medina M, Murillo S, et al. Effects of sardine-enriched diet on metabolic control, inflammation and gut microbiota in drug-naïve patients with type 2 diabetes: a pilot randomized trial. Lipids Health Dis. 2016;15(1):78.
- Lassale C, Batty GD, Baghdadli A, Jacka F, Sánchez-Villegas A, Kivimäki M, Akbaraly T. Correction: healthy dietary indices and risk of depressive outcomes: a systematic review and meta-analysis of observational studies. Mol Psychiatry. 2019;24(7):1094. doi:https://doi.org/10.1038/s41380-018-0299-7.
- Michalak J, Zhang XC, Jacobi F. Vegetarian diet and mental disorders: results from a representative community survey. Int J Behav Nutr Phys Act. 2012;9(1):67. doi:https://doi.org/10.1186/1479-5868-9-67.
- Lavallee K, Zhang XC, Michalak J, Schneider S, Margraf J. Vegetarian diet and mental health: cross-sectional and longitudinal analyses in culturally diverse samples. J Affect Disord. 2019;248:147–54.
- Jain R, Degremont A, Philippou E, Latunde-Dada GO. Association between vegetarian and vegan diets and depression: a systematic review. Proc Nutr Soc. 2020;79(OCE1):E28. doi:https://doi.org/10.1017/S0029665119001496. Epub 01/22.
- Grosso G, Micek A, Marventano S, Castellano S, Mistretta A, Pajak A, Galvano F. Dietary n-3 PUFA, fish consumption and depression: a systematic review and meta-analysis of observational studies. J Affect Disord. 2016;205:269–81. doi:https://doi.org/10.1016/j.jad.2016.08.011.
- Cussotto S, Strain CR, Fouhy F, Strain RG, Peterson VL, Clarke G, et al. Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function. Psychopharmacology. 2019. doi:https://doi.org/10.1007/s00213-018-5006-5. PubMed PMID: 30155748.
- Lukić I, Getselter D, Ziv O, Oron O, Reuveni E, Koren O, Elliott E. Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior. Transl Psychiatry. 2019;9(1):133. doi:https://doi.org/10.1038/s41398-019-0466-x. PubMed PMID: 30967529.
- Ayaz M, Subhan F, Ahmed J, Khan A-u, Ullah F, Ullah I, et al. Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance. J Bio Res-Thessaloniki. 2015;22(1):4.
- Coban AY, Tanriverdi YC, Keleş SU, Durupinar B. Investigation of antibacterial activity of sertralin. Mikrobiyol Bul. 2009;43(4):651–6.
- De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010;107(33):14691–6. doi:https://doi.org/10.1073/pnas.1005963107. PubMed PMID: 20679230; PMCID: 2930426.
- Hill DA, Hoffmann C, Abt MC, Du Y, Kobuley D, Kirn TJ, et al. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol. 2010;3(2):148–58. Epub 2009/11/25. doi:https://doi.org/10.1038/mi.2009.132. PubMed PMID: 19940845.
- Auer L, Lazuka A, Sillam-Dussès D, Miambi E, O’Donohue M, Hernandez-Raquet G. Uncovering the potential of termite gut microbiome for lignocellulose bioconversion in anaerobic batch bioreactors. Front Microbiol. 2017;8:2623.
- Lyte M, Daniels KM, Schmitz-Esser S. Fluoxetine-induced alteration of murine gut microbial community structure: evidence for a microbial endocrinology-based mechanism of action responsible for fluoxetine-induced side effects. Peer J. 2019;7:e6199.
- Amadou T, Hosny M, La Scola B, Cassir N. “Lachnoclostridium bouchesdurhonense,” a new bacterial species isolated from human gut microbiota. New Microbes New Infect. 2016;13:69–70. doi:https://doi.org/10.1016/j.nmni.2016.06.015.
- Luna RA, Oezguen N, Balderas M, Venkatachalam A, Runge JK, Versalovic J, et al. Distinct microbiome-neuroimmune signatures correlate with functional abdominal pain in children with autism spectrum disorder. Cell Mol Gastroenterol Hepatol. 2017;3(2):218–30. doi:https://doi.org/10.1016/j.jcmgh.2016.11.008.
- Lemaire M, Dou S, Cahu A, Formal M, Le Normand L, Romé V, et al. Addition of dairy lipids and probiotic Lactobacillus fermentum in infant formula programs gut microbiota and entero-insular axis in adult minipigs. Sci Rep. 2018;8(1):11656. doi:https://doi.org/10.1038/s41598-018-29971-w.
- Frost G, Sleeth ML, Sahuri-Arisoylu M, Lizarbe B, Cerdan S, Brody L, et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun. 2014;5:3611.
- Wei YB, Melas PA, Wegener G, Mathé AA, Lavebratt C. Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the bdnf gene. Int J Neuropsuchopharmacolog. 2015;18(2). doi:https://doi.org/10.1093/ijnp/pyu032.
- Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut. 1994;35(1 Suppl):S35–S8.
- Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469(7331):543.
- van de Wouw M, Schellekens H, Dinan TG, Cryan JF. Microbiota-gut-brain axis: modulator of host metabolism and appetite. J Nutr. 2017;147(5):727–45. doi:https://doi.org/10.3945/jn.116.240481.
- Skonieczna-Żydecka K, Grochans E, Maciejewska D, Szkup M, Schneider-Matyka D, Jurczak A, et al. Faecal short chain fatty acids profile is changed in Polish depressive women. Nutrients. 2018;10(12):1939.
- Lach G, Schellekens H, Dinan TG, Cryan JF. Anxiety, depression, and the microbiome: a role for gut peptides. Neurotherapeutics. 2018;15(1):36–59. doi:https://doi.org/10.1007/s13311-017-0585-0.
- Zhou L, Foster JA. Psychobiotics and the gut–brain axis: in the pursuit of happiness. Neuropsychiatr Dis Treat. 2015;11:715–723.
- Ohland CL, Kish L, Bell H, Thiesen A, Hotte N, Pankiv E, Madsen KL. Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome. Psychoneuroendocrinology. 2013;38(9):1738–47.
- van de Wouw M, Boehme M, Lyte JM, Wiley N, Strain C, O’Sullivan O, et al. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain–gut axis alterations. J Physiol. 2018;596(20):4923–44.
- DeCastro M, Nankova BB, Shah P, Patel P, Mally PV, Mishra R, La Gamma EF. Short chain fatty acids regulate tyrosine hydroxylase gene expression through a cAMP-dependent signaling pathway. Mol Brain Res. 2005;142(1):28–38.
- Kidd SK, Schneider JS. Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition. Brain Res. 2010;1354:172–8.
- Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701–12. doi:https://doi.org/10.1038/nrn3346. PubMed PMID: 22968153.
- Peng L, He Z, Chen W, Holzman IR, Lin J. Effects of butyrate on intestinal barrier function in a Caco-2 cell Monolayer model of intestinal barrier. Pediatr Res. 2007;61:37. doi:https://doi.org/10.1203/01.pdr.0000250014.92242.f3.
- Bourassa MW, Alim I, Bultman SJ, Ratan RR. Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health? Neurosci Lett. 2016;625:56–63. doi:https://doi.org/10.1016/j.neulet.2016.02.009.
- Mariadason JM, Kilias D, Catto-Smith A, Gibson PR. Effect of butyrate on paracellular permeability in rat distal colonic mucosa ex vivo. J Gastroenterol Hepatol. 1999;14(9):873–9.
- Clarke G, O’Mahony S, Dinan T, Cryan JJ. Priming for health: gut microbiota acquired in early life regulates physiology, brain and behaviour. Acta Paediat. 2014;103(8):812–9.
- Golubeva AV, Crampton S, Desbonnet L, Edge D, O’Sullivan O, Lomasney KW, et al. Prenatal stress-induced alterations in major physiological systems correlate with gut microbiota composition in adulthood. Psychoneuroendocrinology. 2015;60:58–74.
- Huang T-T, Lai J-B, Du Y-L, Xu Y, Ruan L-M, Hu S-HJ. Current understanding of gut microbiota in mood disorders: an update of human studies. Front Genet. 2019;10(98):1–12.
- Upreti VV, Eddington ND. Fluoxetine pretreatment effects pharmacokinetics of 3, 4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat. J Pharmaceut Sci. 2008;97(4):1593–605.
- Altamura AC, Moro AR, Percudani M. Clinical pharmacokinetics of fluoxetine. Clin Pharmacokinet. 1994;26(3):201–14. doi:https://doi.org/10.2165/00003088-199426030-00004. Epub 1994/03/01. PubMed PMID: 8194283.
- Gyuraszova M, Kovalcikova A, Gardlik R. Association between oxidative status and the composition of intestinal microbiota along the gastrointestinal tract. Med Hypotheses. 2017;103:81–5. doi:https://doi.org/10.1016/j.mehy.2017.04.011. Epub 2017/06/03. PubMed PMID: 28571818.
- Panasevich MR, Wankhade UD, Chintapalli SV, Shankar K, Rector RS. Cecal versus fecal microbiota in Ossabaw swine and implications for obesity. Physiol Genomics. 2018;50(5):355–68. doi:https://doi.org/10.1152/physiolgenomics.00110.2017. Epub 2018/03/10. PubMed PMID: 29521600; PMCID: PMC6008116.
- Kozik AJ, Nakatsu CH, Chun H, Jones-Hall YL. Comparison of the fecal, cecal, and mucus microbiome in male and female mice after TNBS-induced colitis. PLoS One. 2019;14(11):e0225079. doi:https://doi.org/10.1371/journal.pone.0225079. Epub 2019/11/09. PubMed PMID: 31703107; PMCID: PMC6839838.
- LeGates TA, Kvarta MD, Thompson SM. Sex differences in antidepressant efficacy. Neuropsychopharmacol. 2019;44:140–154. doi:https://doi.org/10.1038/s41386-018-0156-z.
- Orsini CA, Setlow B. Sex differences in animal models of decision making. J Neurosci Res. 2017;95(1-2):260–9. doi:https://doi.org/10.1002/jnr.23810. Epub 2016/11/22. PubMed PMID: 27870448; PMCID: PMC5120608.
- Ma L, Xu Y, Wang G, Li R. What do we know about sex differences in depression: a review of animal models and potential mechanisms. Prog Neuro-Psychopharmacol Biol Psychiatry. 2019;89:48–56. doi:https://doi.org/10.1016/j.pnpbp.2018.08.026. Epub 2018/08/31. PubMed PMID: 30165122.
- Gertsik L, Poland RE, Bresee C, Rapaport MH. Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder. JJocp. 2012;32(1):61–64.
- Jazayeri S, Tehrani-Doost M, Keshavarz SA, Hosseini M, Djazayery A, Amini H, et al. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Aust NZ J Psychiat. 2008;42(3):192–8.